PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

12 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Geppert, J. & Rohm, M.: Cancer cachexia: Biomarkers and the influence of age. Mol. Oncol., DOI: 10.1002/1878-0261.13590 (2024)
2.
Haase, A.* et al.: New retinoblastoma (RB) drug delivery approaches: Anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB. Mol. Oncol. 18, 832-849 (2024)
3.
Schinke, H.* et al.: Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas. Mol. Oncol. 15, 1040-1053 (2021)
4.
Schinke, H.* et al.: SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival. Mol. Oncol., DOI: 10.1002/1878-0261.13075 (2021)
5.
Bao, X. ; Shi, R.* ; Zhao, T. & Wang, Y.*: Mast cell-based molecular subtypes and signature associated with clinical outcome in early-stage lung adenocarcinoma. Mol. Oncol. 14, 917-932 (2020)
6.
Hedegger, K.* et al.: Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice. Mol. Oncol. 14, 1653-1669 (2020)
7.
Yang, L. et al.: Nonsense-mediated decay factor SMG7 sensitizes cells to TNF alpha-induced apoptosis via CYLD tumor suppressor and the noncoding oncogenePvt1. Mol. Oncol. 14, 2420-2435 (2020)
8.
Keller, S.* et al.: Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines. Mol. Oncol. 12, 441-462 (2018)
9.
Wintergerst, L. et al.: A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC). Mol. Oncol., DOI: 10.1002/1878-0261.12388 (2018)
10.
von Heyking, K.* et al.: The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma. Mol. Oncol. 11, 1288-1301 (2017)
11.
Falkenberg, N. et al.: Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo. Mol. Oncol. 9, 282-294 (2015)
12.
Fröhlich Archangelo, L. et al.: The CALM and CALM/AF10 interactor CATS is a marker for proliferation. Mol. Oncol. 2, 356-367 (2008)
▮◀ ◀◀ ▶▶ ▶▮